Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 05-2022 | 02-2022 | 11-2021 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,201 | 1,849 | 2,147 |
| Receivables | 70 | 121 | 80 |
| Inventories | 114 | N/A | N/A |
| TOTAL | $1,443 | $2,055 | $2,235 |
| Non-Current Assets | |||
| PPE Net | 4 | 5 | 5 |
| Intangibles | 824 | 586 | 310 |
| TOTAL | $828 | $591 | $315 |
| Total Assets | $2,271 | $2,646 | $2,550 |
| Liabilities | |||
| Current Liabilities | |||
| TOTAL | $299 | $482 | $134 |
| Non-Current Liabilities | |||
| Deferred Revenues | N/A | 4 | 4 |
| TOTAL | $0 | $0 | $0 |
| Total Liabilities | $299 | $482 | $134 |
| Shareholders' Equity | |||
| Common Shares | 4,832 | 4,832 | 4,832 |
| Retained earnings | -3,303 | -3,097 | -2,812 |
| Other shareholders' equity | 190 | 190 | 190 |
| TOTAL | $1,972 | $2,164 | $2,416 |
| Total Liabilities And Equity | $2,271 | $2,646 | $2,550 |